| ANG Lifesciences India Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540694 |
NSE Symbol : - |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE236W01016 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 49.98 |
Market Cap(₹Cr) : 27.62 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 18.30 | 25.97 | 24.53 | 17.67 | 23.91 | 32.16 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 18.30 | 25.97 | 24.53 | 17.67 | 23.91 | 32.16 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.16 | 0.21 | 0.17 | 0.75 | -0.03 | 0.36 |
| Total Income | 18.46 | 26.18 | 24.71 | 18.42 | 23.88 | 32.52 |
| Total Expenditure | 20.38 | 23.75 | 22.68 | 18.03 | 25.89 | 29.70 |
| PBIDT | -1.92 | 2.42 | 2.03 | 0.39 | -2.01 | 2.82 |
| Interest | 1.61 | 1.59 | 1.61 | 2.05 | 1.71 | 1.87 |
| PBDT | -3.52 | 0.84 | 0.42 | -1.66 | -3.72 | 0.95 |
| Depreciation | 1.45 | 1.45 | 1.45 | 1.30 | 1.84 | 1.62 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.74 | 0.18 | -0.24 | -1.02 | -1.00 | 0.41 |
| Reported Profit After Tax | -4.24 | -0.80 | -0.79 | -1.94 | -4.57 | -1.07 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -4.24 | -0.80 | -0.79 | -1.94 | -4.57 | -1.07 |
| EPS (Unit Curr.) | -3.23 | -0.60 | -0.59 | -1.50 | -3.50 | -0.75 |
| EPS (Adj) (Unit Curr.) | -3.23 | -0.60 | -0.59 | -1.50 | -3.50 | -0.75 |
| Calculated EPS (Unit Curr.) | -3.25 | -0.61 | -0.60 | -1.48 | -3.50 | -0.82 |
| Calculated EPS (Adj) (Unit Curr.) | -3.25 | -0.61 | -0.60 | -1.48 | -3.50 | -0.82 |
| Calculated EPS (Ann.) (Unit Curr.) | -12.99 | -2.45 | -2.41 | -5.94 | -13.98 | -3.29 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -12.99 | -2.45 | -2.41 | -5.94 | -13.98 | -3.29 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 13.06 | 13.06 | 13.06 | 13.06 | 13.06 | 13.06 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -10.49 | 9.32 | 8.28 | 2.21 | -8.41 | 8.77 |
| PBDTM(%) | -19.23 | 3.23 | 1.71 | -9.39 | -15.56 | 2.95 |
| PATM(%) | -23.17 | -3.08 | -3.22 | -10.98 | -19.11 | -3.33 |
